& Development

Ipsen’s commitment to research & development is our bold promise to patients, to launch at least one new drug or meaningful new indication every year. We will secure our future by building a pipeline of innovative medicines, establishing our leadership position in key therapeutic areas, ensuring sustainable lifecycle management and, most importantly, creating a company of inspiring people throughout our R&D organization.

The patient voice helps us design clinical trials and provide effective therapeutic solutions. Our R&D centers are at the heart of three internationally reputed scientific hubs; Paris-Saclay in France, Cambridge in the U.S.A. and Oxford in the U.K.

Three therapeutic areas

Ipsen focuses on three therapeutic areas, Oncology, Neuroscience and Rare Diseases, developing innovative and differentiated therapies in areas of high unmet medical need. Our specialized portfolio of products, combined with our strong clinical and regulatory skillset, will allow us to continue to expand indications across existing therapies and bring new treatments to patients.